B-Type Natriuretic Peptide in Isolated Severe Tricuspid Regurgitation: Determinants and Impact on Outcome

Chang-Hwan YOON; Joo-Hee ZO; Yong-Jin KIM; Hyung-Kwan KIM; Dong-Ho SHINE; Kyung-Hwan KIM; Ki-Bong KIM; Hyuk AHN; Dae-Won SOHN; Byung-Hee OH; Young-Bae PARK.
Journal of Cardiovascular Ultrasound ; : 139-145, 2010.
Artículo en Inglés | WPRIM | ID: wpr-187780

Documentos relacionados

  1. Right ventricular contractility affects the clinical efficacy of add-on tolvaptan following hospitalization for heart failure in patients with significant tricuspid regurgitation.
  2. Tricuspid regurgitation in pulmonary arterial hypertension: a right ventricular volumetric and functional analysis.
  3. ECG patterns to predict pulmonary arterial hypertension in patients with severe tricuspid regurgitation.
  4. Effect of Telehealth Services on Mitral and Tricuspid Regurgitation Progression: Retrospective Study.
  5. [T-TEER: description of a development process].
  6. [Tricuspid regurgitation: transcatheter treatment by TriClip®].
  7. Prognostic value of tricuspid regurgitation.
  8. Development of significant tricuspid regurgitation over time and prognostic implications: new insights into natural history.
  9. The Fibrosis-4 Index Predicts Cardiovascular Prognosis in Patients With Severe Isolated Tricuspid Regurgitation.
  10. Epidemiological Study of Tricuspid Regurgitation After Cardiac Transplantation. Does it Influence Survival?